Marquette Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Buy
251
+37
+17% +$2.98K ﹤0.01% 238
2026
Q1
$18.5K Buy
214
+25
+13% +$2.4K ﹤0.01% 170
2025
Q4
$18.2K Buy
189
+28
+17% +$2.72K ﹤0.01% 170
2025
Q3
$15.3K Buy
+161
New +$14.8K ﹤0.01% 172
2025
Q2
Sell
-4
Closed -$360 147
2025
Q1
$360 Buy
+4
New +$358 ﹤0.01% 140
2024
Q3
Sell
-132
Closed -$10.4K 247
2024
Q2
$10.4K Buy
+132
New +$10.8K ﹤0.01% 169
2023
Q4
Sell
-244
Closed -$19.1K 254
2023
Q3
$19.1K Hold
244
﹤0.01% 178
2023
Q2
$21.5K Buy
+244
New +$21K 0.01% 182
2022
Q3
Sell
-6
Closed -$1K 328
2022
Q2
$1K Sell
6
-1
-14% -$101 ﹤0.01% 265
2022
Q1
$1K Buy
+7
New +$740 ﹤0.01% 322
2021
Q4
Sell
-36
Closed -$5K 268
2021
Q3
$5K Buy
+36
New +$4.66K ﹤0.01% 248
2019
Q2
Sell
-88
Closed -$8K 278
2019
Q1
$8K Buy
+88
New +$7.88K ﹤0.01% 259

Other funds holding MDT

Marquette Asset Management's MDT Position: Q2 2026 in Review

Marquette Asset Management increased its Medtronic (MDT) stake by 17% in Q2 2026, buying an estimated $2.98K and bringing the position to 251 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

Marquette Asset Management first reported a position in MDT in Q1 2019 and has held it in 12 quarters since. The position peaked at $21.5K in Q2 2023. 836 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Marquette Asset Management held 251 shares of Medtronic worth $19.6K as of Q2 2026.
  • Marquette Asset Management bought 37 Medtronic shares in Q2 2026, an estimated $2.98K.
  • Medtronic made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #238 holding.
  • Marquette Asset Management first reported a position in Medtronic in Q1 2019 and has held it in 12 quarters since.
  • Marquette Asset Management's Medtronic position peaked at $21.5K in Q2 2023.
  • 836 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.